Literature DB >> 12537716

Feasibility of testing for Chlamydia trachomatis in a general population sexual behaviour survey in Slovenia.

I Klavs1, L C Rodrigues, K Wellings, D Kese, I Svab.   

Abstract

Our objective was to assess the feasibility of integrating first void urine (FVU) specimens testing for Chlamydia trachomatis genitourinary infection into a general population sexual behaviour survey. A total of 752 randomly selected respondents aged 18 to 54 were enrolled into the survey. Face to face interviewing with self-administered sensitive questions was used. Overall survey response rate was 77.4%. A convenience sub-sample of 83 respondents were invited to provide FVU specimens for confidential testing for C. trachomatis genitourinary infection. Fifty-five complied. This resulted in 66% FVU specimen participation rate among targeted respondents. Two specimens tested positive by Amplicor polymerase chain reaction. High feasibility study overall response rate indicated good acceptability of the survey. It proved feasible to collect FVU specimens for C. trachomatis testing in the small sub-sample. Consequently, we proceeded with integration of testing for C. trachomatis into the ongoing main survey.

Entities:  

Mesh:

Year:  2002        PMID: 12537716     DOI: 10.1258/095646202762226074

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  2 in total

1.  Prevalence of and risk factors for self-reported sexually transmitted infections in Slovenia in 2000.

Authors:  Marta Grgic-Vitek; Igor Svab; Irena Klavs
Journal:  Croat Med J       Date:  2006-10       Impact factor: 1.351

2.  Prevalence of sexually transmitted infections with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis: findings from the National Survey of Sexual Lifestyles, Attitudes and Health, Slovenia, 2016 to 2017.

Authors:  Irena Klavs; Maja Milavec; Lina Berlot; Tanja Kustec; Marta Grgič-Vitek; Darja Lavtar; Metka Zaletel; Andrej Golle; Darja Duh; Tjaša Žohar Čretnik
Journal:  Euro Surveill       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.